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The Role of Percutaneous Transluminal Angioplasty in the
Treatment of Carotid Fibromuscular Dysplasia
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Fibromuscular dysplasia (FMD) is a disease of unknown aetiology, first typically presenting in the medium and large
arteries of young to middle-aged women. It was first described by Leadbetter and Burkland in 1938 and is most commonly
noted to involve the renal vessels. The management of FMD with severely stenotic and symptomatic lesions has historically
been surgical.
It has been shown previously that percutaneous transluminal angioplasty (PTA) works well in the setting of renal artery
FMD.
We report a case where PTA was used in the treatment of a patient with severe symptomatic internal carotid FMD.
The results in this case appear to suggest that angioplasty can be used as a treatment for internal carotid FMD with good
clinical resolution of symptoms. Further studies are required to assess efficacy, durability, and complication rates.
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Introduction
Fibromuscular dysplasia (FMD) is a disease of
unknown aetiology, first typically presenting in the
medium and large arteries of young to middle-aged
women. It was first described by Leadbetter and
Burkland in 1938.1
FMD affects the renal arteries in the majority (some
estimate up to 85% of diagnosed patients) of patients
undergoing angiography for symptomatic lesions,2
and is associated with renovascular hypertension. The
internal carotid artery (ICA) is the second most
common location, presenting as thromboembolic
stroke, transient ischaemic attacks or features of
cerebral ischemia.
Historically, the management of FMD with severely
stenotic and symptomatic lesions has been surgical.3 – 5
However, with recent advances in endovascular
procedures, it has been well shown that percutaneous
transluminal angioplasty (PTA) works well for fibro-
muscular disease of the renal arteries.6
We report a case which describes the use of PTA in
the treatment of Internal carotid FMD, and review the
relevant literature.
Case Report
A 66-year-old Caucasian woman presented to her GP
with a series of transient ischaemic attacks (TIAs)
involving the right hemisphere, occurring at intervals
of 2 weeks over the previous six month period. She
was commenced on a course of aspirin and referred
to her local consultant neurologist for further
investigation.
Symptoms included left sided weakness and right
sided amaurosis fugax.
There were no other symptoms on systemic
enquiry, with no concurrent comorbidity. She had a
past medical history of hypercholesterolaemia and
hypertension, but was noted to have no other risk
factors for development of atheromatous disease
(being a non-diabetic, non-smoker). She had pre-
viously been investigated for atypical chest pains
and coronary artery disease which was concluded
with a normal coronary angiogram in 1996.
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Persistant medical therapy with aspirin and
dypiridamole did not alter the frequency of TIAs.
Carotid Doppler investigations and subsequent
magnetic resonance angiography (MRA) confirmed
the presence of a severe stenosis at the cervical portion
of right internal carotid.
Cerebral angiography revealed ‘classical fibro-
muscular dysplasia’, with localised beading and
tortuosity of the right ICA. No involvement of the
left ICA or other vessels was noted (Fig. 1).
Treatment was changed to full anticoagulation with
warfarin with a view to reviewing the symptoms and
to consider surgery or further intervention if she
continued to present with these frequent, debilitating
and occasionally severe attacks.
Further to anticoagulation no further TIAs were
noted for a period of 6 months.
Review in follow-up clinic at 8 months post-
presentation, described two further TIAs in quick
succession in the intervening period since she was last
seen, despite being on warfarin.
At this stage, consideration was undertaken for
angioplasty of her carotid artery in view of
persistent symptoms despite optimised medical
therapy. Arrangements were made for in-patient
angiogram ^ PTA.
She underwent angioplasty of her right internal
carotid in July 2000 (Fig. 2). The procedure was
uneventful and she remained neurologically asympto-
matic throughout. There were no post-procedural
complications. She was discharged on aspirin and a
4 week course of dypiridamole.
Results
Follow-up duplex scanning at 3 months, revealed a
patent right ICA without significant stenosis.
Further outpatient follow-up at 4 months post-
procedure, revealed no further neurological events.
At 18 months post-procedure (January 2002), an
MR angiogram (MRA) of her head and neck
showed no evidence of significant change (Fig. 3).
The right ICA was noted to be patent.
At latest follow-up in March 2002, she has had no
further neurological events or symptoms.
Fig. 1. AP view of the patient’s carotid angiogram highlighting classical appearance of FMD—localised beading and
tortuosity in the right ICA.
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Discussion
FMD is an arterial disease of unknown aetiology
typically affecting the medium and large arteries.
Male-to-female ratio is 1:3, with incidence peaking in
the 25–50 age group.7 It typically affects the renal
arteries and often presents as renovascular hyper-
tension (renal vessel involvement accounting for 85%
of diagnoses).2,3,6
Incidence is thought to range geographically
between 1/50 and 1/8 in normotensive people of
a given population. The reported incidence of FMD
in adults is 0.6% via angiography and 1.1% via
autopsy and is thus noted to be under-diagnosed in
asymptomatic patients.
The ICA is the second most common location. Vessels
are affected bilaterally in 65% of patients. Presentation is
as thromboembolic stroke, transient ischaemic attack, or
cerebral ischemia in the same manner as the flow-
disruption in atheromatous cerebrovascular disease. It is
also associated with intra-cranial aneurysm formation
and carotid artery dissection.
On diagnostic angiography, the ‘string of beads’
appearance is considered pathognomonic for FMD
(making it the gold standard investigation for
diagnosis). CT angiography and MRA may also
identify the same appearance in the ICA.
FMD which produces minimally stenotic lesions,
(even those affecting a relatively long segment of
vessel), can be managed conservatively using anti-
platelet and/or anticoagulant therapy.4,7 Interven-
tional treatment is often reserved for those patients
with symptomatic carotid arterial disease as many
patients with documented FMD may have no
symptoms.2
Traditionally, the interventional management of
FMD with severely stenotic symptomatic lesions has
been surgical. Options include endarterectomy,
arterial resection with an interposition graft or intra-
operative intra-arterial dilation with graduated rigid
dilators.8 Surgical excision at the site of the carotid is
more complex technically as it usually requires access
to the restricted upper cervical segment of the ICA
(most commonly affected).
Currently, with advances in balloon catheters and
imaging technology, PTA, with or without stenting,
has become an effective and accepted option
for treatment in patients with significant vascular
stenoses, providing good results in a minimally
invasive fashion. Data to support this, however, is
largely provided in the setting of atheromatous
stenoses rather than in the setting of FMD.9
It is noted that in the renal arteries, angioplasty
alone (without stents) typically provides good and
Fig. 2. Lateral carotid view post-angioplasty showing the now patent right ICA.
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durable results without thrombotic complications.10
Hence PTA alone is now the new accepted treatment of
choice for FMD-related renal vascular hypertension.
Isolated case reports11 – 13 appear to indicate a low
risk of stroke during the carotid procedure, which is
done with neurological assessment prior to, and
during the procedure (as in this case). Despite
suggestion of a low rate of complications in selected
cases, there remains an as yet non-delineated risk of
intimal dissection14 which must be taken into account
in assessment of suitability for undergoing such
intervention. Hence such procedures should only be
conducted under cover of backup vascular surgical
services. It should also be a salient point of discussion
in the risk-benefit analysis.
Further investigation is required to assess efficacy,
durability, and complication rates compared to the
current treatment options. However, successive case
reports11 – 13 suggest evidence of the value of PTA in
the treatment of internal carotid FMD.
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Fig. 3. MRA in January 2002 demonstrating bilaterally patent
ICAs.
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